Hyrule Warriors: Age of Imprisonment (NS2) has debuted in first place on the French charts for week 45, 2025, according to SELL. Mario Kart World (NS2) remained in third place, while Pokémon Legends: ...
Hyrule Warriors: Age of Imprisonment (NS2) has debuted in first place on the retail charts in Japan with sales of 73,183 units, according to Famitsu for the week ending November 9, 2025. Dragon Quest ...
CAC of 0 associated with a very low proportion of coronary artery disease-related and total cardiovascular deaths. (HealthDay News) — A coronary artery calcium (CAC) score of 0 has excellent prognosis ...
In a new study of more than 40,000 patients, researchers at Intermountain Health in Salt Lake City have found that patients who have no evidence of calcium in their coronary arteries are not only ...
Your credit score can impact everything from the rate you get on a mortgage to whether or not you qualify for a credit card. But most people have no idea how their credit score stacks up against ...
Listen to Listen to your heart — it might be trying to tell you more than you think. A new study found that your score on a key cardiovascular test may indicate your risk of dying in the coming years ...
Coronary artery calcium may be a predictor for all-cause mortality, including non-cardiac conditions
In a new study of more than 40,000 patients, researchers at Intermountain Health in Salt Lake City have found that patients who have no evidence of calcium in their coronary arteries are not only ...
Coronary artery calcium (CAC) CT scans are becoming a more commonly used tool to effectively determine a patient's future risk of heart disease and heart attack. These minimally invasive scans measure ...
NFL star Amon-Ra St. Brown's Donald Trump gesture goes viral Deer attacks 70-year-old woman in yard, sending her to hospital, NC officials say Chris Hemsworth, Alzheimer's and why Hollywood is ...
Oct 29 (Reuters) - BridgeBio Pharma's (BBIO.O), opens new tab experimental drug for a rare genetic condition that causes low blood calcium met all the main and secondary goals in a late-stage study, ...
BridgeBio Pharma is having a banner week, with the Bay Area company’s encaleret acing a phase 3 trial just days after another late-stage rare disease win as its eyes an FDA review in 2026. In the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback